Skye Bioscience, Inc.SKYENASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending higher, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-30.19M
↓ 149% below average
Average (9y)
$-12.13M
Historical baseline
Range
High:$-3.86M
Low:$-34.74M
CAGR
+24.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-30.19M | +13.1% |
| 2023 | $-34.74M | -89.7% |
| 2022 | $-18.31M | -133.3% |
| 2021 | $-7.85M | -24.8% |
| 2020 | $-6.29M | +5.2% |
| 2019 | $-6.63M | -41.3% |
| 2018 | $-4.69M | -21.6% |
| 2017 | $-3.86M | +13.7% |
| 2016 | $-4.47M | -3.6% |
| 2015 | $-4.32M | - |